ID   L1210/R81
AC   CVCL_N028
SY   L1210 (R81)
DR   ChEMBL-Cells; CHEMBL3307415
DR   ChEMBL-Targets; CHEMBL614710
DR   PubChem_Cell_line; CVCL_N028
DR   Wikidata; Q54900965
RX   PubMed=3965926;
CC   Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 14
//
RX   PubMed=3965926;
RA   Rosowsky A., Forsch R.A., Galivan J., Susten S.S., Freisheim J.H.;
RT   "Regiospecific gamma-conjugation of methotrexate to poly(L-lysine).
RT   Chemical and biological studies.";
RL   Mol. Pharmacol. 27:141-147(1985).
//